For the year ending 2025-12-31, PHAT has $259,149K in assets. $697,318K in debts. $129,972K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 129,972 | |||
| Prepaid expenses and other current assets | 15,353 | |||
| Accounts receivable, net | 78,129 | |||
| Inventory | 5,518 | |||
| Total current assets | 228,972 | |||
| Total property and equipment, gross | 4,539 | |||
| Less accumulated depreciation and amortization | 3,475 | |||
| Property and equipment, net | 1,064 | |||
| Operating lease right-of-use assets | 2,603 | |||
| Restricted cash | 2,861 | |||
| Inventory, non-current | 20,732 | |||
| Other long-term assets | 2,917 | |||
| Total assets | 259,149 | |||
| Accounts payable | 4,983 | |||
| Accrued expenses | 89,831 | |||
| Accrued interest | 1,833 | |||
| Operating lease liabilities, current | 648 | |||
| Current portion of revenue interest financing liability | 27,249 | |||
| Other current liabilities | 7,500 | |||
| Total current liabilities | 132,044 | |||
| Long-term debt, net of discount | 209,087 | |||
| Revenue interest financing liability | 350,122 | |||
| Operating lease liabilities | 2,065 | |||
| Other long-term liabilities | 4,000 | |||
| Total liabilities | 697,318 | |||
| Common stock, 0.0001 par value authorized shares - 400,000,000 at december 31, 2025 and december 31, 2024 issued and outstanding shares - 71,419,025 and 68,518,238 at december 31, 2025 and december 31, 2024, respectively | 6 | |||
| Treasury stock - 19 shares at december 31, 2025 and december 31, 2024 | 0 | |||
| Additional paid-in capital | 1,046,083 | |||
| Accumulated deficit | -1,484,258 | |||
| Total stockholders' deficit | -438,169 | |||
| Total liabilities and stockholders' deficit | 259,149 | |||
Phathom Pharmaceuticals, Inc. (PHAT)
Phathom Pharmaceuticals, Inc. (PHAT)